Aparna Nathan

Aparna is a freelance science writer pursuing a PhD in bioinformatics and genomics at Harvard University. She uses her multidisciplinary training to find both the cutting-edge science and the human stories in everything from genetic testing to space expeditions. She was recently a 2021 AAAS Mass Media Fellow at the Philadelphia Inquirer. Her writing has also appeared in Popular SciencePBS NOVA, and The Open Notebook.

Articles by Aparna Nathan
Abstract Genetics Disease stock photo
Bridging Disciplines to Study CRISPR-Induced Chromosome Destabilization
Aparna Nathan | Apr 8, 2022
A collaboration between friends led to a cautionary finding about CRISPR’s effect on cells.
Engineered Bacteria Make Tumors More T Cell-Friendly
Engineered Bacteria Make Tumors More T Cell-Friendly
Aparna Nathan | Apr 8, 2022
Microbes designed to produce specific immunomodulatory metabolites could give immunotherapy a boost.
Erika More developed a jello-like tissue system to study how immune cells stimulate tissues and blood vessel growth.
An Engineer’s Perspective on Autoimmunity
Aparna Nathan | Dec 10, 2021
Erika Moore builds biomaterials to study disparate lupus outcomes.
Christmas background
Helping the Immune System Keep its Cool
Aparna Nathan | Dec 10, 2021
Researchers found that lowering the temperature alleviates autoimmunity in mice.
800x560 istock image
Training Immune Cells to Be Cancer Killers
Aparna Nathan | Nov 12, 2021
A career-altering experience as a cancer patient motivated one researcher to design more potent immunotherapies.
istock image 800x560
Can mRNA Vaccine Momentum Propel Tumor Immunotherapies?
Aparna Nathan | Nov 12, 2021
A guide to mRNA-based cancer vaccines and where they’re headed next
istock-845814134-800x560
Early Successes Make CRISPR-Based Medicine a Possibility
Aparna Nathan | Oct 25, 2021
CRISPR-Cas9’s molecular scissors—thus far limited to the lab bench—may soon find themselves at work directly in the human body.
untitled-design
From Bench to Boardroom
Aparna Nathan | Oct 25, 2021
Taking inspiration from her PhD research, Ana Moreno formed a company where scientists use CRISPR to treat chronic pain
Environmental Cues Keep CAR T Cells on Track
Aparna Nathan | May 25, 2021
Pairing CARs with a synthetic receptor makes T cells more lethal tumor killers.